Yundan Liao

Yundan Liao

Auto-generated profile, based on publicly available information

Yundan Liao

Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
ZLZhe Lu
Zhe Lu
CPchengcheng pu
chengcheng pu
YZYuyanan Zhang
Yuyanan Zhang
YSYAOYAO SUN
YAOYAO SUN
YLYundan Liao
Yundan Liao
WYWeihua Yue
Weihua Yue
Observational studies have shown that oxidative stress is highly related to psychiatric disorders, while its cause–effect remains unclear. To this end, a Mendelian randomization study was performed to investigate the causal relationship between oxidative stress and psychiatric disorders. On the one hand, all causal effects of oxidative stress injury biomarkers (OSIB) on psychiatric disorders were not significant (p > 0.0006), while the findings suggested that part of OSIB was nominally associated with the risk of psychiatric disorders (causal OR of uric acid (UA), 0.999 for bipolar disorder (BD), and 1.002 for attention-deficit/hyperactivity disorder (ADHD); OR of catalase was 0.903 for anorexia nervosa (AN); OR of albumin was 1.162 for autism; p < 0.05). On the other hand, major depressive disorder (MDD) was significantly associated with decreased bilirubin (p = 2.67 × 10−4); ADHD was significantly associated with decreased ascorbate (p = 4.37 × 10−5). Furthermore, there were also some suggestively causal effects of psychiatric disorders on OSIB (BD on decreased UA and increased retinol; MDD on increased UA and decreased ascorbate; schizophrenia on decreased UA, increased retinol and albumin; ADHD on increased UA, and decreased catalase, albumin, and bilirubin; AN on decreased UA). This work presented evidence of potential causal relationships between oxidative stress and psychiatric disorders.

1 February 2026 in American Journal of Psychiatry
Verified
Journal Article
Closed access
GZGuorui Zhao
Guorui Zhao
YSYaoyao Sun
Yaoyao Sun
YZYuyanan Zhang
Yuyanan Zhang
TLTianlan Lu
Tianlan Lu
ZLZhe Lu
Zhe Lu
WYWeihua Yue
Weihua Yue

20 May 2025 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
ZLZhe Lu
Zhe Lu
JGJing Guo
Jing Guo
JSJunyuan Sun
Junyuan Sun
YSYAOYAO SUN
YAOYAO SUN
YZYing Zhang
Ying Zhang
WYWeihua Yue
Weihua Yue
Objective This study aims to compare and rank event-related potentials (ERP) components among healthy individuals and patients with various psychiatric disorders, including schizophrenia (SCZ), bipolar disorder (BD), major depressive disorder (MDD), anxiety disorder (AD), and obsessive-compulsive disorder (OCD). Methods A comprehensive search was conducted in PubMed, Embase, PsycINFO, and Web of Science up to March 20th, 2024. Original studies reporting ERP component data in patients with psychiatric disorders were included. Network meta-analyses were conducted to compare ERP components, including P300, mismatch negative (MMN), P50, N1, N2, P1, and P2. Results From 47,391 citations, 687 studies were included, with sample sizes ranging from 893 to 16,879. Compared to healthy controls (HC), significant reduction in amplitudes and latency delay of P300, and reduced MMN amplitude were observed in SCZ, BD, and MDD. Additionally, SCZ displayed significant abnormalities in all P50 components. Reductions in N1, N2, and P2 amplitudes were noted in SCZ, with increased N2 latencies in SCZ and BD. The most significant difference across psychosis in EPR components was the MMN amplitude and ERN amplitude between OCD and SCZ. Finally, the composite ERP-score suggested SCZ rank the first in ERP abnormalities. Most primary outcomes were stable in sensitivity analyses. Conclution The findings suggested that SCZ exhibited pronounced electrophysiological abnormalities, particularly in the P300 and P50 components. Moreover, the results provided a comprehensive overview of the varying electrophysiological profiles across different psychoses. These insights support the potential of ERPs as neurophysiological markers reflecting the neural dysfunctions associated with these disorders. Prospero registration: CRD42022361158

27 March 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
ZLZhe Lu
Zhe Lu
YYYang Yang
Yang Yang
GZGuorui Zhao
Guorui Zhao
YZYuyanan Zhang
Yuyanan Zhang
YSYAOYAO SUN
YAOYAO SUN
WYWeihua Yue
Weihua Yue
Redox regulatory drug (RRD) targets may be considered potential novel drug targets of psychosis due to the fact that the brain is highly susceptible to oxidative stress imbalance. The aim of the present study is to identify potential associations between RRD targets’ perturbation and the risk of psychoses; to achieve this, Mendelian randomization analyses were conducted. The expression quantitative trait loci (eQTL) and protein QTL data were used to derive the genetic instrumental variables. We obtained the latest summary data of genome-wide association studies on seven psychoses as outcomes, including schizophrenia (SCZ), bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder, autism, obsessive–compulsive disorder and anorexia nervosa. In total, 95 unique targets were included in the eQTL panel, and 48 targets in the pQTL one. Genetic variations in the vitamin C target (OGFOD2, OR = 0.784, p = 2.14 × 10−7) and melatonin target (RORB, OR = 1.263, p = 8.80 × 10−9) were significantly related to the risk of SCZ. Genetic variation in the vitamin E (PRKCB, OR = 0.248, p = 1.24 × 10−5) target was related to an increased risk of BD. Genetic variation in the vitamin C target (P4HTM: cerebellum, OR = 1.071, p = 4.64 × 10−7; cerebellar hemisphere, OR = 1.092, p = 1.98 × 10−6) was related to an increased risk of MDD. Cognitive function mediated the effects on causal associations. In conclusion, this study provides supportive evidence for a causal association between RRD targets and risk of SCZ, BD or MDD, which were partially mediated by cognition.

12 February 2026 in Journal of Affective Disorders
Verified
Journal Article
Open access
YLYunhan Lin
Yunhan Lin
BLBiman Najika Liyanage
Biman Najika Liyanage
CXChenyang Xu
Chenyang Xu
ZZZhengwen Zhu
Zhengwen Zhu
YLYundan Liao
Yundan Liao
WYWeihua Yue
Weihua Yue
Speech encodes emotional, cognitive, and motor states, offering an objective, non-invasive window into mental health. In major depressive disorder (MDD), vocal alterations are reported, yet their cross-dataset reproducibility, symptom specificity, and longitudinal stability remain uncertain, especially under naturalistic, content-variable speech tasks. We conducted a large, multi-cohort study of 1857 participants spanning a primary discovery dataset, an independent secondary clinical dataset, and an 8-week longitudinal follow-up. From standardized recordings we extracted 6373 acoustic features and examined (i) baseline case-control screening in each dataset, (ii) severity-related feature patterns across depression levels, (iii) symptom-dimension markers using stability-enhanced elastic net, and (iv) longitudinal feature changes over 8 weeks, integrating unsupervised clustering and mediation analyses, with false discovery rate control. Across cohorts, correlation-based redundancy reduction yielded a compact final set of 23 non-redundant representative features for cross-cohort reporting and interpretation. Symptom-factor analysis identified distinct, non-overlapping feature sets for HAMD-24 dimensions, with somatic and depressed mood yielding the most stable markers. Longitudinally, 38 features exhibited heterogeneous recovery trajectories and mediation patterns consistent with symptom improvement, with spectral-shape and modulation markers showing higher temporal sensitivity than energy and voice-quality features. Overall, our findings indicate that a compact set of speech-derived markers can support symptom-informed monitoring in MDD. A small subset of acoustic features is robust, symptom-specific, and temporally informative, refining assumptions of uniform vocal change and enabling targeted, symptom-informed speech biomarkers for personalized monitoring and early intervention. Future work should verify these markers using task-matched speech prompts and alternative feature representations, given potential content-related confounding in free-response speech and reported reliability limitations of some high-dimensional acoustic feature toolkits. TRIAL REGISTRATION: ChiCTR2500095151.

23 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RSRachel L. Smith
Rachel L. Smith
YLYundan Liao
Yundan Liao
LKLambertus Klei
Lambertus Klei
LZLujing Zhang
Lujing Zhang
YMYunlong Ma
Yunlong Ma
MGMichael J. Gandal
Michael J. Gandal
Summary: Our companion sequencing study uncovered 253 genes robustly associated with autism spectrum disorder (ASD), yet the biological programs they impact, and the cellular, developmental, and spatial contexts in which they converge, remain unresolved. Here we systematically contextualize genes associated with ASD across neurodevelopment and cortical areas, integrating developmental single-cell and spatial atlases with gene- and isoform co-expression, regulatory, proteomic, and synaptic networks. Genetic burden concentrates within temporally-resolved neuronal subclasses: newborn excitatory neurons, immature interneurons, and maturing intratelencephalic lineages. Genes associated with ASD converge on three functional programs—gene regulation, neuronal morphogenesis, and synaptic transmembrane signaling machinery—resolved from 28 ASD-associated networks, several of which are directly regulated by ASD genes including MEF2C , SOX11 , and FOXP2 . These programs are spatially patterned, with risk genes exhibiting an increasing anterior-to-posterior cortical expression gradient, anchored in the primary visual cortex and driven by excitatory neuron gene-regulatory programs. Finally, ASD risk genes associated with more severe developmental phenotypes show broader excitatory neuron enrichment and less interneuron involvement. Together, these findings anchor ASD genetic vulnerability to specific neurodevelopmental lineages, epochs, and molecular substrates, and delineate the features that distinguish ASD from comorbidities with broader developmental impacts.